Sex-specific risk factors associated with graves' orbitopathy in Korean patients with newly diagnosed graves' disease

被引:1
|
作者
Lee, Jooyoung [1 ]
Kang, Jinmo [1 ]
Ahn, Hwa Young [2 ]
Lee, Jeong Kyu [3 ]
机构
[1] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea
[2] Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[3] Chung Ang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
THYROID-ASSOCIATED OPHTHALMOPATHY; MULTIPLE IMPUTATION; SEVERITY; SMOKING; AGE;
D O I
10.1038/s41433-023-02513-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
ObjectiveTo assess sex-specific risk factors for Graves' orbitopathy (GO) in newly diagnosed Graves' disease (GD) patients.MethodsA retrospective cohort study was conducted using the National Health Insurance Service's sample database, which consisted of 1,137,861 subjects from 2002 to 2019. The international classification of disease-10 codes was used to identify those who developed GD (E05) and GO (H062). A multivariable Cox proportional hazards model was used to estimate the effect of risk factors on GO development.ResultsAmong 2145 male and 5047 female GD patients, GO occurred in 134 men (6.2%) and 293 women (5.8%). A multivariable Cox regression model revealed that GO development was significantly associated with younger age (HR = 0.84, 95% CI = 0.73-0.98), low income (HR = 0.55, 95% CI = 0.35-0.86), and heavy drinking (HR = 1.79, 95% CI = 1.10-2.90) in men, and with younger age (HR = 0.89, 95% CI = 0.81-0.98), lower body mass index (HR = 0.55, 95% CI = 0.33-0.90), high total cholesterol (HR = 1.04, 95% CI = 1.01-1.06), hyperlipidaemia (HR = 1.37, 95% CI = 1.02-1.85), and lower statin dose (HR = 0.37, 95% CI = 0.22-0.62) in women. There was no association between smoking and GO development in both men and women.ConclusionsThe risk factors for GO development were sex-dependent. These results show the need for more sophisticated attention and support considering sex characteristics in GO surveillance.
引用
收藏
页码:3382 / 3391
页数:10
相关论文
共 50 条
  • [31] Muscle Performance and Postural Stability Are Reduced in Patients with Newly Diagnosed Graves' Disease
    Malmstroem, Sofie
    Grove-Laugesen, Diana
    Riis, Anne Lene
    Bruun, Bjarke Johannessen
    Ebbehoj, Eva
    Hansen, Klavs Wuergler
    Watt, Torquil
    Rejnmark, Lars
    THYROID, 2019, 29 (06) : 783 - 789
  • [32] Impact of Graves Disease on Ocular Surface and Corneal Epithelial Thickness in Patients With and Without Graves Orbitopathy
    Carreira, Ana Rita
    Rodrigues-Barros, Sandra
    Moraes, Filipe
    Loureiro, Tomas
    Machado, Ines
    Campos, Paul
    Cardoso, Joao Nobre
    Campos, Nuno
    CORNEA, 2022, 41 (04) : 443 - 449
  • [33] Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy
    Le Moli, R.
    Muscia, V.
    Tumminia, A.
    Frittitta, L.
    Buscema, M.
    Palermo, F.
    Sciacca, L.
    Squatrito, S.
    Vigneri, R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (05) : 452 - 457
  • [34] The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy
    Bartalena, Luigi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03): : 592 - 599
  • [35] Candidate gene associations reveal sex-specific Graves' disease risk alleles among Chinese Han populations
    Yan, Chen-Yan
    Ma, Yu-Ru
    Sun, Feng
    Zhang, Rui-Jia
    Fang, Ya
    Zhang, Qian-Yue
    Wu, Feng-Yao
    Zhao, Shuang-Xia
    Song, Huai-Dong
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (07):
  • [36] Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities
    Maurizio Bifulco
    Elena Ciaglia
    Endocrine, 2016, 53 : 649 - 650
  • [37] Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy
    Ogmen, Berna Evranos
    Ugurlu, Nagihan
    Bilginer, Muhammet Cuneyt
    Polat, Sefika Burcak
    Genc, Birgul
    Ersoy, Reyhan
    Cakir, Bekir
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (11) : 3397 - 3405
  • [38] Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy
    Edmunds, Matthew R.
    Boelaert, Kristien
    THYROID, 2019, 29 (04) : 557 - 562
  • [39] Statin reduces orbitopathy risk in patients with Graves' disease by modulating apoptosis and autophagy activities
    Bifulco, Maurizio
    Ciaglia, Elena
    ENDOCRINE, 2016, 53 (03) : 649 - 650
  • [40] Antigen-specific therapy of Graves' disease and orbitopathy by induction of tolerance
    Ungerer, Martin
    Fassbender, Julia
    Holthoff, Hans-Peter
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 2044 - 2052